Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.

Á¶·çÁõ ȯÀÚ¿¡¼­ À½°æÀÇ Áøµ¿°¨°¢¿ªÄ¡, À½°æ¹èºÎ½Å°æ ±¸½É¼º ½Å°æÀüµµ·ÎÀÇ »óÅ¿¡ µû¸¥ °æ±¸¿ë ¾à¹°¿ä¹ýÀÇ È¿°ú Efficacy of Oral Pharmacotherapy according to Results of Biothesiometry, BCRL and DNSEP in Patients with Premature Ejaculation

´ëÇѺñ´¢±â°úÇÐȸÁö 1998³â 39±Ç 6È£ p.597 ~ 600
ÇÑÁö¿±, ±è¿µÁÖ, ±èÁø¼ö,
¼Ò¼Ó »ó¼¼Á¤º¸
ÇÑÁö¿± (  ) 
Áß¾Ó´ëÇб³ ÀÇ°ú´ëÇÐ ºñ´¢±â°úÇб³½Ç

±è¿µÁÖ (  ) 
Áß¾Ó´ëÇб³ ÀÇ°ú´ëÇÐ ºñ´¢±â°úÇб³½Ç
±èÁø¼ö (  ) 
Áß¾Ó´ëÇб³ ÀÇ°ú´ëÇÐ ºñ´¢±â°úÇб³½Ç

Abstract

¼­·Ð
»çÁ¤ÀÇ ½Å°æ»ý¸®´Â ¾ÆÁ÷ ÃæºÐÈ÷ ÀÌÇصÇÁö ¾Ê°í ÀÖÁö¸¸, »çÁ¤ÀÇ ´ë³ú¼¾ÅÍ´Â µµÆĹμº ÀÚ±Ø
¿¡ ÀÇÇØ ±àÁ¤Àû ¹æÇâÀ¸·Î Á¶ÀýµÇ¸ç, ¼¼·ÎÅä´Ñ¼º Àڱؿ¡ ÀÇÇØ ºÎÁ¤Àû ¹æÇâÀ¸·Î Á¶ÀýµÈ´Ù°í
¾Ë·Á Á® ÀÖ´Ù. ¸»ÃÊÀûÀ¸·Î´Â ¥á1-¼ö¿ëüÀÇ È°¼ºÀ¸·Î Àü´ÞµÇ¸ç, Äݸ°¼º ½Å°æ
¶ÇÇÑ °ü¿©µÇ´Â °ÍÀ¸·Î ÃßÁ¤µÇ°í ÀÖ´Ù. »ïȯ°è Ç׿ì¿ïÁ¦(tricyclic anti-depressants, TCA)ÀÎ
clomipramineÀ̳ª ¼±ÅÃÀû ¼¼·ÎÅä´Ñ ÀçÈí¼ö ¾ïÁ¦Á¦ (selective serotonin reuptake inhibitor;
SSRI)ÀÎ sertraline, fluoxetine, paroxetine µîÀÇ ¾àÁ¦µéÀº ±× ±âÀüÀº ¸íÈ®ÇÏÁö ¾ÊÀ¸³ª ¼¼·Î
Åä´ÑÀÇ ÀçÈí¼ö¸¦ ¾ïÁ¦ÇÔÀ¸·Î½á »çÁ¤ÀÇ ´ë³ú ¼¾Å¸¿¡ ´ëÇØ ¼¼·ÎÅä´ÑÀÌ °è¼Ó ºÎÁ¤Àû ¹æÇâÀ¸·Î
ÀÛ¿ëÇÏ°Ô ÇÏ¿© »çÁ¤½Ã°£À» ¿¬Àå½ÃÄÑ ÁÖ´Â °ÍÀ¸·Î »ý°¢µÇ°í ÀÖ´Ù. ô¼öÀÇ ´©Á¤
(T10-L2) ȤÀº »çÁ¤ (S2-4) ÁßÃß¿Í ±× ÇϺÎÀÇ ÀÚ
À²½Å°æ°è¿¡ ´ëÇÑ ¿µÇâÀº ºÒÈ®½ÇÇÏ´Ù. ±âÁú¼º ¿øÀο¡ ÀÇÇÑ Á¶·çÁõÀÇ ¹ß»ý±âÀü¿¡ ´ëÇؼ­´Â Çö
Àç ³í¶õÀÇ ¿©Áö°¡ ¸¹À¸³ª À½°æ ƯÈ÷, ±ÍµÎÀÇ °¨°¢ °ú¹ÎÀ̳ª °úÈïºÐ, »çÁ¤°ú °ü·ÃµÈ õ¼ö ¹Ý
»ç±ÃÀÇ Á¶±â ÈïºÐ, À½°æ¹èºÎ½Å°æÀÇ ¸»ÃÊ ¹× ÁßÃß ±¸½É¼º ½Å°æÀüµµ·ÎÀÇ ÀÌ»ó µî¿¡ ÀÇÇØ ¹ß»ý
ÇÒ ¼öµµ ÀÖ´Â °ÍÀ¸·Î º¸°íµÇ°íÀÖ´Ù. ÀÌ·¯ÇÑ ±âÁú¼º Á¶·çÁõÀÇ Áø´ÜÀ» À§ÇØ ÁÖ·Î ÀÌ¿ë µÇ°í
ÀÖ´Â À½°æÁøµ¿°¢ÃøÁ¤¼ú, ±¸Çظéü¹Ý»çÁö¿¬(bulvo-cavernous reflex latency, BCRL) °Ë»ç¿Í
À½°æ¹èºÎ½Å°æü°¨°¢À¯¹ßÀüÀ§ (dorsal nerve somatosensory evoked potential; DNSEP)°Ë»ç
»ó Ưº°ÇÑ ÀÌ»ó ¼Ò°ßÀÌ ¾ø´Â Á¶·çÁõ ȯÀÚ Áï, ½É¸®Àû ¿øÀÎÀ̳ª ´ë³úÀÇ »çÁ¤ÁßÃßÀÇ ÀÌ»óÀ¸·Î
ÀÎÇØ Á¶·çÁõÀÌ À¯¹ßµÇ¾úÀ» °¡´É¼ºÀÌ ³ôÀº ȯÀÚ¿¡ ´ëÇØ TCA ȤÀº SSRI¸¦ Åõ¿©ÇÏ¿´À» ¶§,
º¸´Ù ¾çÈ£ÇÑ »çÁ¤Áö¿¬È¿°ú¸¦ ±â´ëÇØ º¼ ¼öµµ ÀÖ´Ù. ÀÌ¿¡ ÀúÀÚµéÀº Á¶·çÁõ ȯÀÚ¿¡ ´ëÇÑ À½°æ
Áøµ¿°¢ÃøÁ¤¼ú, BCRL °Ë»ç, DNSEP°Ë»ç °á°ú¿Í TCA¶Ç´Â SSRI¿¡ ÀÇÇÑ »çÁ¤Áö¿¬È¿°úÀÇ »ó
°ü°ü°è¸¦ Á¶»çÇÏ¿© ÀÌµé °Ë»ç°¡ ÀÌµé ¾àÁ¦ÀÇ »çÁ¤Áö¿¬È¿°ú¸¦ ¿¹ÃøÇÒ ¼ö ÀÖ´Â ÁöÇ¥°¡ µÉ ¼ö
ÀÖ´ÂÁö¸¦ ±Ô¸íÇÏ°íÀÚ º» ¿¬±¸¸¦ °èȹÇÏ¿´´Ù.
#ÃÊ·Ï#
Purpose : To determine whether biothesiometry, bulbocavernous reflex latency(BCRL),
and dorsal nerve somatosensory evoked potential(DNSEP) test could predict efficacy of
tricyclic antidepressant(TCA) or selective serotonin reuptake inhibitor(SSRI) to prolong
the ejaculatory latency in premature ejaculation.
Materials and Methods : A total of 33 patients with pramature ejaculation(mean age:
44 years) completed the entire study, Patients took each of clomipramine(50mg),
sertraline(1 00mg), and fluoxetine(40mg) consecutively during a 4-week period per each
agent. We obtained increased intravaginal ejaculatory latency by the most effective drug
among 3 drugs. We analyzed correlations of the increased intravaginal ejaculatory
latency with vibration threshold of penile shaft and glans, BCRL, and latency and
amplitude of DNSEP.
Results : According to Pearson's correlation analysis, there was no correlation of
intravaginal ejaculatory latency with vibration threshold of penile shaft and glans, BCRL,
and latency and amplitude of DNSEP(all p>0.05). There was no difference in
intravaginal ejaculatory latency between the groups of high and low vibration threshold,
long and short BCRL, long and short latency of DNSEP, and large and small amplitude
at cerebral cortex on DNSEP test(all p>0.05).
Conclusions : It seems that biothesiometry, BCRL, and DNSEP test can not predict
the efficacy of tricyclic antidepressant or selective serotonin reuptake inhibitor to prolong
the ejaculatory latency in premature ejaculation. (Korean J Urol 1998; 39: 597¡­600)

Premature ejaculation2 Oral pharmacotherapy; Biothesiometry; Bulbocavernous reflex latency; Dorsal nerve somatosensory evoked potential;

Å°¿öµå

¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸

   

µîÀçÀú³Î Á¤º¸

KCI
KoreaMed
KAMS